The subcutaneous route exists for researchers using a lyophilized vial format, but it is limited to small doses
Its antioxidant, anti-inflammatory, cytoprotective, immunomodulatory, antibacterial, and antibiofilm properties make it a valuable adjuvant in diverse chronic and infectious respiratory diseases
Beyond demonstrating efficacy in clinical trials, healthcare stakeholders increasingly seek evidence on comparative effectiveness, long-term outcomes, quality of life, treatment pathways, and healthcare resource utilization in routine clinical practice
Gu Y, Bartolom-Casado R, Xu C, Bertocchi A, Janney A, Heuberger C, et al
Wurth MA, Sayeed MM, Baue AE
Combined treatment with sodium-glucose cotransporter-2 inhibitor (Canagliflozin) and dipeptidyl peptidase-4 inhibitor (Teneligliptin) alleviates NASH progression in a non-diabetic rat model of steatohepatitis